AVEO Oncology (NASDAQ: AVEO) announced the presentation of final results, including a predefined biomarker analysis, from the BATON- (Biomarker Assessment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE